NCT00481078View on ClinicalTrials.gov

Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer

Interventions

DRUG

vorinostat

Given PO

DRUG

paclitaxel

Given IV

DRUG

carboplatin

Given IV

OTHER

placebo

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91010

City of Hope, Duarte

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00481078 - Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter